choose content

Choose content

Enter keywords to create a newsletter
create account

Create account

Enter your registration information
set preferences

Set preferences

Set up your newsletter name, delivery and time zone preferences
Hint: Enter different keywords to generate new results.

Now you can:

  1. Search the news index.
  2. Browse more than 1 million newsletters by category.
  3. Use preset newsletters:
    • Pharmaceutical Sales

Pharmaceutical Sales Newsletter
  • Pfizer profits dip on lower Covid-19 related sales 04 Nov 2025 13:35 GMT

    … quarter profits Tuesday as lower sales of Covid-19 products … 7 billion. The big US drugmaker, which has been navigating a … a Covid vaccine. Lower sales in Covid-related products were … maker Metsera. The Danish pharmaceutical giant last week announced an …

  • India’s Alembic Pharma posts quarterly profit jump on strong generics demand 04 Nov 2025 10:58 GMT

    (Reuters) -Indian drugmaker Alembic Pharmaceuticals posted a 20.4% rise … , click [here] KEY CONTEXT Alembic Pharma and several of Indian peers … No. of Stock to Div Sales growth (%) growth rating* analyst … 12 0.90 1.19 Pharmaceuticals Dr Reddy’s 20.33 …

  • India’s Gland Pharma posts higher quarterly profit on Cenexi boost 03 Nov 2025 13:03 GMT

    … Carbonatix (Reuters) -India’s Gland Pharma reported a 12% rise in … .87 billion rupees. U.S. sales, which make up more than … Dr Reddy’s reported subdued sales in the region during the … higher, the company said. The drugmaker had been grappling with production …

  • Pharmaceutical market poised for growth following Malaysia-US agreement 03 Nov 2025 12:32 GMT

    … (US) pharmaceutical companies are likely to see increased sales in Malaysia … year will continue pressuring pharmaceutical margins through enhanced government … operations and profitability of pharmaceutical companies. "Drugmakers may face challenges …

  • Shot in the arm for Indian drugmakers as US FDA moves to ease biosimilar approvals 01 Nov 2025 23:52 GMT

    For Indian drugmakers grappling with uncertainty over potential US tariffs on pharmaceutical imports … total revenues—surpassing even domestic sales. FDA’S PUSH TO MAKE … Pharmaceuticals last year highlighted that 24 blockbuster drugs with combined global sales

  • Massive sales for weight loss drugs spur Eli Lilly’s Q3 01 Nov 2025 19:15 GMT

    … in the pharma industry. The drug’s sales have overtaken … strong performance, the US drugmaker increased its 2025 full … you deserve! The Pharmaceutical Technology Excellence Awards celebrate … among top leaders driving pharmaceutical advancements. Don’t …

  • The day pharma’s weight-loss gold rush intensified 31 Oct 2025 06:15 GMT

    … and shunned by large drugmakers. Much-anticipated medicines failed … valuable pharmaceutical company worth $800 billion thanks to blockbuster sales … the potential, every large drugmaker has been eyeing the weight … It is unusual for drugmakers to seek to undo …

  • How Trump’s do-or-die agenda is impacting Big Pharma’s CEO chatter 30 Oct 2025 12:37 GMT

    … have forced drugmakers to adjust, and Big Pharma leaders have … years, joining fellow drugmakers making pledges to avoid … drugmaker reacting to tariff threats with U.S. consolidation. Fellow pharma … role of pharmacy benefit managers, hospital drug sales under …

  • Earnings roundup: Alnylam’s down day, Neurocrine’s head scratch and Biogen’s ‘low quality’ win 30 Oct 2025 22:41 GMT

    … the latest numbers from Alnylam Pharmaceuticals, Biogen, Neurocrine Biosciences … sky-high expectations Alnylam Pharmaceuticals has been among the … large-cap drugmakers, at least in terms of sales and … million building out the sales teams for Ingrezza and …

  • J&J To Be in Sync with Trump Administration as MFN Spreads 25 Oct 2025 06:10 GMT

    … soon stabilize for many Big Pharma companies. All this puts Johnson … very interesting position, as the drugmaker went ahead and led the … also made direct-to-consumer sales channels and also tougher … now anticipates reeling in 2025 sales between $93.5 billion …

Satisfied with the content?

Continue to create your account.